These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9393289)

  • 1. Prognostic implications of cytogenetic findings in kidney cancer.
    Elfving P; Mandahl N; Lundgren R; Limon J; Bak-Jensen E; Fernö M; Olsson H; Mitelman F
    Br J Urol; 1997 Nov; 80(5):698-706. PubMed ID: 9393289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
    Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
    Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Independent value of tumor size and DNA ploidy for the prediction of disease progression in patients with organ-confined renal cell carcinoma.
    Di Silverio F; Casale P; Colella D; Andrea L; Seccareccia F; Sciarra A
    Cancer; 2000 Feb; 88(4):835-43. PubMed ID: 10679653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53 expression in correlation to clinical outcome in patients with renal cell carcinoma.
    Ljungberg B; Bozoky B; Kovacs G; Stattin P; Farrelly E; Nylander K; Landberg G
    Scand J Urol Nephrol; 2001 Feb; 35(1):15-20. PubMed ID: 11291681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
    del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
    Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impacts of cytogenetic findings in clear cell renal cell carcinoma: gain of 5q31-qter predicts a distinct clinical phenotype with favorable prognosis.
    Gunawan B; Huber W; Holtrup M; von Heydebreck A; Efferth T; Poustka A; Ringert RH; Jakse G; Füzesi L
    Cancer Res; 2001 Nov; 61(21):7731-8. PubMed ID: 11691785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in renal cell carcinoma.
    Ljungberg B
    Urologe A; 2004 Sep; 43 Suppl 3():S119-20. PubMed ID: 15179550
    [No Abstract]   [Full Text] [Related]  

  • 9. Prognostic evaluation of DNA flow cytometry and histo-morphological criteria in renal cell carcinoma.
    Eskelinen M; Lipponen P; Nordling S
    Anticancer Res; 1995; 15(5B):2279-83. PubMed ID: 8572637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.
    Tsui KH; Shvarts O; Smith RB; Figlin RA; deKernion JB; Belldegrun A
    J Urol; 2000 Apr; 163(4):1090-5; quiz 1295. PubMed ID: 10737472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric assessment of deoxyribonucleic acid content in renal adenocarcinoma: does ploidy status enhance prognostic stratification over stage alone?
    Currin SM; Lee SE; Walther PJ
    J Urol; 1990 Mar; 143(3):458-63. PubMed ID: 2304153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
    Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
    Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of the prognostic value of DNA ploidy and proliferation index (Ki-67) in renal cell carcinoma with venous thrombus].
    Rey D; Pfister C; Gobet F; Martinez S; Staerman F; Grise P
    Prog Urol; 2003 Dec; 13(6):1300-6. PubMed ID: 15000303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic profile predicts prognosis of patients with clear cell renal cell carcinoma.
    Klatte T; Rao PN; de Martino M; LaRochelle J; Shuch B; Zomorodian N; Said J; Kabbinavar FF; Belldegrun AS; Pantuck AJ
    J Clin Oncol; 2009 Feb; 27(5):746-53. PubMed ID: 19124809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological and clinical implication of cellular DNA content in renal cell carcinomas.
    Di Silverio F; Gallucci M; Flammia GP; De Vico A; Caponera M; Eleuteri P; Forte D; Cavallo D; De Vita R
    Eur Urol; 1992; 21 Suppl 1():43-7. PubMed ID: 1425835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histological subtyping and nuclear grading of renal cell carcinoma and their implications for survival: a retrospective nation-wide study of 629 patients.
    Gudbjartsson T; Hardarson S; Petursdottir V; Thoroddsen A; Magnusson J; Einarsson GV
    Eur Urol; 2005 Oct; 48(4):593-600. PubMed ID: 15964127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appraisal of intratumoral microvessel density, MIB-1 score, DNA content, and p53 protein expression as prognostic indicators in patients with locally confined renal cell carcinoma.
    Gelb AB; Sudilovsky D; Wu CD; Weiss LM; Medeiros LJ
    Cancer; 1997 Nov; 80(9):1768-75. PubMed ID: 9351546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-2 protein and DNA ploidy in renal cell carcinoma: do they affect patient prognosis?
    Skolarikos A; Alivizatos G; Bamias A; Mitropoulos D; Ferakis N; Deliveliotis C; Dimopoulos MA
    Int J Urol; 2005 Jun; 12(6):563-9. PubMed ID: 15985079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric deoxyribonucleic acid analysis in stage I renal cell carcinoma.
    Ljungberg B; Larsson P; Stenling R; Roos G
    J Urol; 1991 Sep; 146(3):697-9. PubMed ID: 1875475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Traditional and future criteria for progression in renal cell carcinoma. Molecular biology and clinical aspects].
    Pomer S; Staehler G
    Urologe A; 1996 May; 35(3):254-62. PubMed ID: 8711834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.